Greenland Mines Ltd (GRML)
NASDAQ: GRML · Real-Time Price · USD
0.256
+0.046 (21.86%)
At close: Jun 26, 2026, 4:00 PM EDT
0.250
-0.006 (-2.27%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Company Description
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses.
The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland.
The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer’s disease, as well as therapies to treat Parkinson’s and other age-related disorders.
The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026.
Greenland Mines Ltd is based in Charlotte, North Carolina.
Greenland Mines Ltd
| Country | United States |
| Industry | Other Precious Metals & Mining |
| Sector | Materials |
| Employees | 5 |
| CEO | Joseph Sinkule |
Contact Details
Address: 1300 South Boulevard, Unit D Charlotte, North Carolina 28203 United States | |
| Phone | 833 931 6330 |
| Website | greenlandmines.com |
Stock Details
| Ticker Symbol | GRML |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001907223 |
| CUSIP Number | 49876K103 |
| ISIN Number | US49876K1034 |
Key Executives
| Name | Position |
|---|---|
| Dr. Joseph A. Sinkule Pharm.D. | Founder, Chief Executive Officer, Chairman of the Board and Secretary |
| Jeffrey LeBlanc | Chief Financial Officer |
| Dr. Shalom Z. Hirschman M.D. | Medical Advisor and Director |
| Peter J. Moriarty | Chief Business Officer |
| Dr. Bo Moller Stensgaard | President |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Officer and Consultant |
| Dr. Gustavo L.A. Delendatti B.Sc (Hons), MAIG, Ph.D. | Vice President of Exploration |
| Dr. Jakob Kløve Keiding | Chief Geologist |